Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salbutamol performance response in healthy trained individuals
NCT04615611Unknown
- Sponsor
- University of Copenhagen
- Start
- Nov 2020
- Primary completion
- Nov 2021
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial in asthma comparing Salbutamol with Placebo (2 arms). Primary endpoint: Sprint performance at 0.5 hours. Status: unknown.
02
Drugs
salbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT04615611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04615611.